United States Rifaximin Market Report 2016

December 2016 | 98 pages | ID: UAACB4F150CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Rifaximin

Revenue, means the sales value of Rifaximin

This report studies sales (consumption) of Rifaximin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Laboratories (US)
• Pharmos Corporation (US)
• Sucampo Pharmaceuticals, Inc. (US)
• Lexicon Pharmaceuticals (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Rifaximin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Rifaximin Market Report 2016

1 RIFAXIMIN OVERVIEW

1.1 Product Overview and Scope of Rifaximin
1.2 Classification of Rifaximin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Rifaximin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Rifaximin (2011-2021)
  1.4.1 United States Rifaximin Sales and Growth Rate (2011-2021)
  1.4.2 United States Rifaximin Revenue and Growth Rate (2011-2021)

2 UNITED STATES RIFAXIMIN COMPETITION BY MANUFACTURERS

2.1 United States Rifaximin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Rifaximin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Rifaximin Average Price by Manufactures (2015 and 2016)
2.4 Rifaximin Market Competitive Situation and Trends
  2.4.1 Rifaximin Market Concentration Rate
  2.4.2 Rifaximin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES RIFAXIMIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Rifaximin Sales and Market Share by Type (2011-2016)
3.2 United States Rifaximin Revenue and Market Share by Type (2011-2016)
3.3 United States Rifaximin Price by Type (2011-2016)
3.4 United States Rifaximin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES RIFAXIMIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Rifaximin Sales and Market Share by Application (2011-2016)
4.2 United States Rifaximin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES RIFAXIMIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Laboratories (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Rifaximin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Laboratories (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pharmos Corporation (US)
  5.2.2 Rifaximin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pharmos Corporation (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sucampo Pharmaceuticals, Inc. (US)
  5.3.2 Rifaximin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Lexicon Pharmaceuticals (US)
  5.4.2 Rifaximin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Lexicon Pharmaceuticals (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview

6 RIFAXIMIN MANUFACTURING COST ANALYSIS

6.1 Rifaximin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Rifaximin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Rifaximin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Rifaximin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES RIFAXIMIN MARKET FORECAST (2016-2021)

10.1 United States Rifaximin Sales, Revenue Forecast (2016-2021)
10.2 United States Rifaximin Sales Forecast by Type (2016-2021)
10.3 United States Rifaximin Sales Forecast by Application (2016-2021)
10.4 Rifaximin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rifaximin
Table Classification of Rifaximin
Figure United States Sales Market Share of Rifaximin by Type in 2015
Table Application of Rifaximin
Figure United States Sales Market Share of Rifaximin by Application in 2015
Figure United States Rifaximin Sales and Growth Rate (2011-2021)
Figure United States Rifaximin Revenue and Growth Rate (2011-2021)
Table United States Rifaximin Sales of Key Manufacturers (2015 and 2016)
Table United States Rifaximin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rifaximin Sales Share by Manufacturers
Figure 2016 Rifaximin Sales Share by Manufacturers
Table United States Rifaximin Revenue by Manufacturers (2015 and 2016)
Table United States Rifaximin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Rifaximin Revenue Share by Manufacturers
Table 2016 United States Rifaximin Revenue Share by Manufacturers
Table United States Market Rifaximin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Rifaximin Average Price of Key Manufacturers in 2015
Figure Rifaximin Market Share of Top 3 Manufacturers
Figure Rifaximin Market Share of Top 5 Manufacturers
Table United States Rifaximin Sales by Type (2011-2016)
Table United States Rifaximin Sales Share by Type (2011-2016)
Figure United States Rifaximin Sales Market Share by Type in 2015
Table United States Rifaximin Revenue and Market Share by Type (2011-2016)
Table United States Rifaximin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rifaximin by Type (2011-2016)
Table United States Rifaximin Price by Type (2011-2016)
Figure United States Rifaximin Sales Growth Rate by Type (2011-2016)
Table United States Rifaximin Sales by Application (2011-2016)
Table United States Rifaximin Sales Market Share by Application (2011-2016)
Figure United States Rifaximin Sales Market Share by Application in 2015
Table United States Rifaximin Sales Growth Rate by Application (2011-2016)
Figure United States Rifaximin Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories (US) Basic Information List
Table Abbott Laboratories (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (US) Rifaximin Sales Market Share (2011-2016)
Table Pharmos Corporation (US) Basic Information List
Table Pharmos Corporation (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pharmos Corporation (US) Rifaximin Sales Market Share (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Basic Information List
Table Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales Market Share (2011-2016)
Table Lexicon Pharmaceuticals (US) Basic Information List
Table Lexicon Pharmaceuticals (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lexicon Pharmaceuticals (US) Rifaximin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rifaximin
Figure Manufacturing Process Analysis of Rifaximin
Figure Rifaximin Industrial Chain Analysis
Table Raw Materials Sources of Rifaximin Major Manufacturers in 2015
Table Major Buyers of Rifaximin
Table Distributors/Traders List
Figure United States Rifaximin Production and Growth Rate Forecast (2016-2021)
Figure United States Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Table United States Rifaximin Production Forecast by Type (2016-2021)
Table United States Rifaximin Consumption Forecast by Application (2016-2021)